Invivoscribe
Biotechnology Research • 
San Diego, California, United States • 101-200 Employees
Company overview
| Headquarters | 10222 Barnes Canyon Rd, Building 1, San Diego, California 92121, US |
| Phone number | +18582246600 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Companion Diagnostics, ASR, Next-Generation Sequencing, Gmp Manufacturing Of Ruo, Precision Diagnostics, Ce-Marked Products |
| Founded | 1995 |
| Employees | 101-200 |
| Socials |
Key Contacts at Invivoscribe
Robert Andrews
Director, Global Flow Cytometry
Kathleen Demarest
Director Human Resources
Thomas Penny
Associate Director Of Business Development And Sales - Americas
Andrew Schut
Associate Director Of Clinical Affairs
Parth Sitlani
Associate Director, Commercial - Emea & Apac
Don Huffman
Global Director Of Facility Management
Craig Ingram
Director, Manufacturing And Supply Chain
Jordan Thornes
Global Operations Director
Laurie Lombardo
Director, Program Management
Tony Galuhn
Associate Director Of Software Engineering
Invivoscribe Email Formats
Invivoscribe uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@invivoscribe.com), used 68.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@invivoscribe.com | 68.8% |
{first initial}{last name} | jdoe@invivoscribe.com | 28.4% |
{2char} | {2char}@invivoscribe.com | 1.8% |
About Invivoscribe
Invivoscribe® is a global leader dedicated to Improving Lives with Precision Diagnostics®, advancing the quality of healthcare by providing innovative products and clinical services for oncology. Our Streamlined CDx® (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. With products manufactured in our state-of-the-art cGMP facility, we provide a comprehensive range of platform agnostic assays, reagents, controls and software for clonal gene rearrangements, translocations, gene mutation testing, and measurable residual disease (MRD). Invivoscribe’s products consistently surpass industry and regulatory standards and play a crucial role in identifying, stratifying and monitoring hematologic cancers, enabling scientific advancements and empowering clinicians to make informed treatment decisions. Our subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM®), offers extensive clinical diagnostic and biopharma services for the detection and monitoring of myelo- and lymphoproliferative disorders. The LabPMM network performs globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations, providing results that are critically important for patient care in the U.S., Europe, and Asia. Join us in our mission to revolutionize oncology diagnostics and improve patient outcomes worldwide. Visit our website to discover how Invivoscribe’s ecosystem is driving advancements in precision medicine.
Invivoscribe revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $52,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $32,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Invivoscribe has 94 employees across 14 departments.
Departments
Number of employees
Funding Data
Invivoscribe has never raised funding before.
Invivoscribe Tech Stack
Discover the technologies and tools that power Invivoscribe's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Security
Live chat
JavaScript libraries
UI frameworks
Video players
Caching
Cookie compliance
JavaScript libraries
JavaScript libraries
JavaScript libraries
United Arab Emirates
France
United Kingdom
Italy
Australia
NetherlandsFrequently asked questions
4.8
40,000 users
